Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$22.18
-0.10-0.45%
At close: -
$22.18
0.000.00%
After Hours: Jun 13, 4:00 PM EDT
Comments
Loading...
IDEAYA Biosciences Analyst Ratings and Price Targets | NASDAQ:IDYA | Benzinga
IDEAYA Biosciences Inc has a consensus price target of $46.17 based on the ratings of 19 analysts. The high is $68 issued by Stifel on September 10, 2024. The low is $24 issued by Baird on November 18, 2022. The 3 most-recent analyst ratings were released by JP Morgan, Stephens & Co., and RBC Capital on May 22, 2025, February 14, 2025, and January 15, 2025, respectively. With an average price target of $59 between JP Morgan, Stephens & Co., and RBC Capital, there's an implied 166.01% upside for IDEAYA Biosciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
JP Morgan
Stephens & Co.
RBC Capital
Wedbush
Leerink Partners
1calculated from analyst ratings
Analyst Ratings for IDEAYA Biosciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/22/2025 | Buy Now | 197.57% | JP Morgan | Anupam Rama60% | $63 → $66 | Maintains | Overweight | Get Alert |
| 02/14/2025 | Buy Now | 125.43% | Stephens & Co. | Sudan Loganathan42% | $50 → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 01/15/2025 | Buy Now | 175.02% | RBC Capital | Gregory Renza52% | $61 → $61 | Reiterates | Outperform → Outperform | Get Alert |
| 01/13/2025 | Buy Now | — | Cantor Fitzgerald | Li Watsek42% | — | Reiterates | Overweight → Overweight | Get Alert |
| 12/17/2024 | Buy Now | — | Cantor Fitzgerald | Li Watsek42% | — | Reiterates | Overweight → Overweight | Get Alert |
| 12/17/2024 | Buy Now | 134.45% | Wedbush | Robert Driscoll45% | $52 → $52 | Reiterates | Outperform → Outperform | Get Alert |
| 11/18/2024 | Buy Now | 129.94% | Stephens & Co. | Sudan Loganathan42% | → $51 | Initiates | → Overweight | Get Alert |
| 11/05/2024 | Buy Now | 21.73% | Leerink Partners | Christopher Liu51% | $41 → $27 | Downgrade | Outperform → Market Perform | Get Alert |
| 10/29/2024 | Buy Now | 138.95% | Oppenheimer | Matthew Biegler39% | $53 → $53 | Reiterates | Outperform → Outperform | Get Alert |
| 10/24/2024 | Buy Now | 125.43% | UBS | David Dai30% | → $50 | Initiates | → Buy | Get Alert |
| 09/24/2024 | Buy Now | 134.45% | Wedbush | Robert Driscoll45% | $54 → $52 | Maintains | Outperform | Get Alert |
| 09/24/2024 | Buy Now | 175.02% | RBC Capital | Gregory Renza52% | $61 → $61 | Reiterates | Outperform → Outperform | Get Alert |
| 09/10/2024 | Buy Now | 206.58% | Stifel | Benjamin Burnett45% | $63 → $68 | Maintains | Buy | Get Alert |
| 08/27/2024 | Buy Now | 161.5% | Citigroup | Yigal Nochomovitz54% | $60 → $58 | Maintains | Buy | Get Alert |
| 08/08/2024 | Buy Now | 197.57% | JP Morgan | Anupam Rama60% | $69 → $66 | Maintains | Overweight | Get Alert |
| 08/07/2024 | Buy Now | 175.02% | RBC Capital | Gregory Renza52% | $61 → $61 | Reiterates | Outperform → Outperform | Get Alert |
| 08/07/2024 | Buy Now | 143.46% | Wedbush | Robert Driscoll45% | $54 → $54 | Reiterates | Outperform → Outperform | Get Alert |
| 08/07/2024 | Buy Now | 138.95% | Oppenheimer | Matthew Biegler39% | $60 → $53 | Maintains | Outperform | Get Alert |
| 07/12/2024 | Buy Now | 211.09% | JP Morgan | Anupam Rama60% | $65 → $69 | Maintains | Overweight | Get Alert |
| 07/11/2024 | Buy Now | 175.02% | RBC Capital | Gregory Renza52% | $53 → $61 | Maintains | Outperform | Get Alert |
| 07/09/2024 | Buy Now | 179.53% | BTIG | Justin Zelin40% | $55 → $62 | Maintains | Buy | Get Alert |
| 07/08/2024 | Buy Now | 184.04% | Stifel | Benjamin Burnett45% | $63 → $63 | Maintains | Buy | Get Alert |
| 07/08/2024 | Buy Now | 170.51% | Oppenheimer | Matthew Biegler39% | $53 → $60 | Maintains | Outperform | Get Alert |
| 07/08/2024 | Buy Now | 125.43% | Mizuho | Graig Suvannavejh52% | → $50 | Initiates | → Outperform | Get Alert |
| 06/04/2024 | Buy Now | 184.04% | Stifel | Benjamin Burnett45% | $55 → $63 | Maintains | Buy | Get Alert |
| 05/13/2024 | Buy Now | 107.39% | Goldman Sachs | Corinne Jenkins47% | $53 → $46 | Maintains | Buy | Get Alert |
| 05/08/2024 | Buy Now | 134.45% | Wedbush | Robert Driscoll45% | $52 → $52 | Reiterates | Outperform → Outperform | Get Alert |
| 03/21/2024 | Buy Now | 170.51% | Citigroup | Yigal Nochomovitz54% | $40 → $60 | Maintains | Buy | Get Alert |
| 03/08/2024 | Buy Now | 147.97% | BTIG | Justin Zelin40% | → $55 | Initiates | → Buy | Get Alert |
| 02/23/2024 | Buy Now | 156.99% | JP Morgan | Anupam Rama60% | $51 → $57 | Maintains | Overweight | Get Alert |
| 02/21/2024 | Buy Now | 138.95% | RBC Capital | Gregory Renza52% | $43 → $53 | Maintains | Outperform | Get Alert |
| 01/26/2024 | Buy Now | 138.95% | Goldman Sachs | Corinne Jenkins47% | $36 → $53 | Maintains | Buy | Get Alert |
| 01/25/2024 | Buy Now | 138.95% | Goldman Sachs | Corinne Jenkins47% | $36 → $53 | Maintains | Buy | Get Alert |
| 01/10/2024 | Buy Now | 93.87% | RBC Capital | Gregory Renza52% | $36 → $43 | Maintains | Outperform | Get Alert |
| 12/06/2023 | Buy Now | 62.31% | RBC Capital | Gregory Renza52% | $36 → $36 | Reiterates | Outperform → Outperform | Get Alert |
| 11/30/2023 | Buy Now | 84.85% | JP Morgan | Anupam Rama60% | $35 → $41 | Maintains | Overweight | Get Alert |
| 11/13/2023 | Buy Now | 93.87% | Wedbush | Robert Driscoll45% | → $43 | Reiterates | Outperform → Outperform | Get Alert |
| 11/08/2023 | Buy Now | 98.38% | Guggenheim | Vanck Zhu75% | $48 → $44 | Maintains | Buy | Get Alert |
| 11/08/2023 | Buy Now | 93.87% | Wedbush | Robert Driscoll45% | → $43 | Reiterates | Outperform → Outperform | Get Alert |
| 10/24/2023 | Buy Now | 62.31% | RBC Capital | Gregory Renza52% | $32 → $36 | Maintains | Outperform | Get Alert |
| 10/11/2023 | Buy Now | 44.27% | RBC Capital | Gregory Renza52% | → $32 | Reiterates | Outperform → Outperform | Get Alert |
| 09/12/2023 | Buy Now | 93.87% | Wedbush | Robert Driscoll45% | $40 → $43 | Maintains | Outperform | Get Alert |
| 09/12/2023 | Buy Now | 66.82% | Goldman Sachs | Corinne Jenkins47% | $31 → $37 | Maintains | Buy | Get Alert |
| 08/17/2023 | Buy Now | 44.27% | JP Morgan | Anupam Rama60% | $28 → $32 | Maintains | Overweight | Get Alert |
| 08/11/2023 | Buy Now | 44.27% | RBC Capital | Gregory Renza52% | $30 → $32 | Maintains | Outperform | Get Alert |
| 08/11/2023 | Buy Now | 80.34% | Wedbush | Robert Driscoll45% | $35 → $40 | Maintains | Outperform | Get Alert |
| 08/11/2023 | Buy Now | 57.8% | Oppenheimer | Matthew Biegler39% | $30 → $35 | Maintains | Outperform | Get Alert |
| 08/08/2023 | Buy Now | 48.78% | SVB Leerink | Christopher Liu51% | → $33 | Initiates | → Outperform | Get Alert |
| 05/24/2023 | Buy Now | 44.27% | Goldman Sachs | Corinne Jenkins47% | → $32 | Initiates | → Buy | Get Alert |
| 04/24/2023 | Buy Now | 80.34% | Guggenheim | Vanck Zhu75% | $32 → $40 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | 8.21% | Stifel | Benjamin Burnett45% | $18 → $24 | Upgrade | Hold → Buy | Get Alert |
| 03/23/2023 | Buy Now | 17.22% | Berenberg | Zhiqiang Shu21% | → $26 | Initiates | → Buy | Get Alert |
| 03/08/2023 | Buy Now | 44.27% | Guggenheim | Charles Zhu64% | → $32 | Reiterates | → Buy | Get Alert |
| 03/08/2023 | Buy Now | 12.71% | RBC Capital | Gregory Renza52% | → $25 | Reiterates | → Outperform | Get Alert |
| 02/28/2023 | Buy Now | 12.71% | RBC Capital | Gregory Renza52% | → $25 | Initiates | → Outperform | Get Alert |
| 12/28/2022 | Buy Now | 30.75% | Capital One | Zegbeh Jallah65% | → $29 | Initiates | → Overweight | Get Alert |
| 11/18/2022 | Buy Now | 8.21% | Baird | Joel Beatty69% | $18 → $24 | Maintains | Outperform | Get Alert |
| 10/27/2022 | Buy Now | 17.22% | Citigroup | Yigal Nochomovitz54% | → $26 | Initiates | → Buy | Get Alert |
| 09/13/2022 | Buy Now | 44.27% | Guggenheim | Charles Zhu64% | $20 → $32 | Maintains | Buy | Get Alert |
| 08/16/2022 | Buy Now | -18.85% | Baird | Joel Beatty69% | $26 → $18 | Maintains | Outperform | Get Alert |
| 08/16/2022 | Buy Now | -9.83% | Oppenheimer | Matthew Biegler39% | $25 → $20 | Maintains | Outperform | Get Alert |
| 08/15/2022 | Buy Now | -41.39% | Stifel | Benjamin Burnett45% | $16 → $13 | Downgrade | Buy → Hold | Get Alert |
FAQ
What is the target price for IDEAYA Biosciences (IDYA) stock?
The latest price target for IDEAYA Biosciences (NASDAQ:IDYA) was reported by JP Morgan on May 22, 2025. The analyst firm set a price target for $66.00 expecting IDYA to rise to within 12 months (a possible 197.57% upside). 24 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for IDEAYA Biosciences (IDYA)?
The latest analyst rating for IDEAYA Biosciences (NASDAQ:IDYA) was provided by JP Morgan, and IDEAYA Biosciences maintained their overweight rating.
When was the last upgrade for IDEAYA Biosciences (IDYA)?
The last upgrade for IDEAYA Biosciences Inc happened on April 24, 2023 when Stifel raised their price target to $24. Stifel previously had a hold for IDEAYA Biosciences Inc.
When was the last downgrade for IDEAYA Biosciences (IDYA)?
The last downgrade for IDEAYA Biosciences Inc happened on November 5, 2024 when Leerink Partners changed their price target from $41 to $27 for IDEAYA Biosciences Inc.
When is the next analyst rating going to be posted or updated for IDEAYA Biosciences (IDYA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IDEAYA Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IDEAYA Biosciences was filed on May 22, 2025 so you should expect the next rating to be made available sometime around May 22, 2026.
Is the Analyst Rating IDEAYA Biosciences (IDYA) correct?
While ratings are subjective and will change, the latest IDEAYA Biosciences (IDYA) rating was a maintained with a price target of $63.00 to $66.00. The current price IDEAYA Biosciences (IDYA) is trading at is $22.18, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
